Stock listing
Frankfurt:EII Eisai Co., Ltd. Aktie
German listing (Frankfurt) of Eisai Co., Ltd. · home listing Tokyo:4523
Follow Eisai Co., Ltd. into a list and get an email when it puts out news.
Share price · FWB:EII
€29.71 EUR -1.04 (-3.4%)
Close on Nov 20, 2026
- Day range
- €29.61 – €29.71 EURNov 20, 2026
- Market cap
- €8.37B EURAt the close on Nov 20, 2026 · price × 281.9M shares outstanding
- 52-week range
- €19.82 – €30.97 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €22,467 EURMedian day 0 shares · 34 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:ESAIY | $8.28 USD | +0.06 (+0.7%) | 500 | $8.25 | $8.28 | $8.25 | $8.22 | Close on Nov 20, 2026 |
| OTC:ESALF | $33.06 USD | +0.48 (+1.5%) | 200 | $33.06 | $33.06 | $33.06 | $32.58 | Close on Nov 16, 2026 |
| Frankfurt:EII | €29.71 EUR | -1.04 (-3.4%) | — | €29.61 | €29.71 | €29.61 | €30.75 | Close on Nov 20, 2026 |
| Munich:EII | €30.06 EUR | +0.01 (0.0%) | — | €30.06 | €30.06 | €30.06 | €30.05 | Close on Nov 20, 2026 |
| Dusseldorf:EII | €29.49 EUR | -0.27 (-0.9%) | — | €30.00 | €30.00 | €29.49 | €29.76 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:EII · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €26.93 | -3.813 | -12.4% | €26.93 | €26.93 | €26.93 | 2,080 | |
| €30.74 | +3.251 | +11.8% | €29.56 | €30.97 | €29.43 | 0 | |
| €27.49 | -0.379 | -1.4% | €27.49 | €27.49 | €27.49 | 340 | |
| €27.87 | -0.164 | -0.6% | €27.87 | €27.87 | €27.87 | 0 | |
| €28.03 | -0.177 | -0.6% | €28.03 | €28.03 | €28.03 | 300 | |
| €28.21 | -0.134 | -0.5% | €28.55 | €28.58 | €28.21 | 2,596 | |
| €28.35 | -0.713 | -2.5% | €28.18 | €28.40 | €28.13 | 3,798 | |
| €29.06 | +0.395 | +1.4% | €28.80 | €29.28 | €28.65 | 642 | |
| €28.66 | -0.748 | -2.5% | €29.15 | €29.46 | €28.62 | 2,774 | |
| €29.41 | -0.208 | -0.7% | €29.36 | €29.86 | €29.33 | 17,252 | |
| €29.62 | +1.387 | +4.9% | €28.89 | €29.92 | €28.89 | 1,420 | |
| €28.23 | +0.276 | +1.0% | €28.24 | €28.24 | €28.14 | 360 | |
| €27.96 | +0.561 | +2.0% | €27.96 | €27.96 | €27.96 | 300 | |
| €27.40 | -0.006 | 0.0% | €27.40 | €27.40 | €27.40 | 0 | |
| €27.40 | +0.10 | +0.4% | €27.40 | €27.40 | €27.40 | 0 | |
| €27.30 | +0.203 | +0.7% | €27.30 | €27.30 | €27.30 | 0 | |
| €27.10 | +0.944 | +3.6% | €27.10 | €27.10 | €27.10 | 900 | |
| €26.15 | +0.095 | +0.4% | €26.15 | €26.15 | €26.15 | 0 | |
| €26.06 | +0.556 | +2.2% | €26.06 | €26.06 | €26.06 | 0 | |
| €25.50 | -0.208 | -0.8% | €25.50 | €25.50 | €25.50 | 0 | |
| €25.71 | -0.288 | -1.1% | €25.71 | €25.71 | €25.71 | 382 | |
| €26.00 | +0.198 | +0.8% | €26.00 | €26.00 | €26.00 | 44 | |
| €25.80 | -0.299 | -1.1% | €25.80 | €25.80 | €25.80 | 0 | |
| €26.10 | -0.012 | 0.0% | €26.10 | €26.10 | €26.10 | 0 | |
| €26.11 | -0.312 | -1.2% | €26.11 | €26.11 | €26.11 | 0 | |
| €26.42 | -0.389 | -1.5% | €26.42 | €26.42 | €26.42 | 1,102 | |
| €26.81 | +0.063 | +0.2% | €26.85 | €26.90 | €26.53 | 100 | |
| €26.75 | +0.483 | +1.8% | €26.75 | €26.75 | €26.75 | 0 | |
| €26.27 | -0.818 | -3.0% | €26.27 | €26.27 | €26.27 | 0 | |
| €27.09 | -0.098 | -0.4% | €27.09 | €27.09 | €27.09 | 0 | |
| €27.18 | +0.554 | +2.1% | €27.18 | €27.18 | €27.18 | 0 | |
| €26.63 | -0.241 | -0.9% | €26.63 | €26.63 | €26.63 | 0 | |
| €26.87 | -0.711 | -2.6% | €26.87 | €26.87 | €26.87 | 0 | |
| €27.58 | +0.73 | +2.7% | €27.58 | €27.58 | €27.58 | 0 | |
| €26.85 | +0.023 | +0.1% | €26.91 | €27.08 | €26.55 | 40 | |
| €26.83 | -0.252 | -0.9% | €26.83 | €26.83 | €26.83 | 800 | |
| €27.08 | -0.282 | -1.0% | €27.08 | €27.08 | €27.08 | 0 | |
| €27.36 | +1.268 | +4.9% | €26.44 | €27.66 | €26.24 | 1,800 | |
| €26.09 | +0.203 | +0.8% | €26.09 | €26.09 | €26.09 | 0 | |
| €25.89 | +0.166 | +0.6% | €25.89 | €25.89 | €25.89 | 0 | |
| €25.73 | -0.369 | -1.4% | €25.73 | €25.73 | €25.73 | 0 | |
| €26.09 | +0.708 | +2.8% | €25.79 | €26.10 | €25.58 | 380 | |
| €25.39 | -0.16 | -0.6% | €25.39 | €25.39 | €25.39 | 0 | |
| €25.55 | +0.431 | +1.7% | €25.55 | €25.55 | €25.55 | 0 | |
| €25.12 | -0.409 | -1.6% | €25.12 | €25.12 | €25.12 | 0 | |
| €25.52 | -1.313 | -4.9% | €25.52 | €25.52 | €25.52 | 510 | |
| €26.84 | +1.376 | +5.4% | €26.02 | €26.86 | €25.90 | 80 | |
| €25.46 | +0.213 | +0.8% | €25.46 | €25.46 | €25.46 | 0 | |
| €25.25 | -0.035 | -0.1% | €25.25 | €25.25 | €25.25 | 0 | |
| €25.28 | -0.307 | -1.2% | €25.28 | €25.28 | €25.28 | 0 | |
| €25.59 | +0.252 | +1.0% | €25.59 | €25.59 | €25.59 | 7,650 | |
| €25.34 | -0.665 | -2.6% | €25.34 | €25.34 | €25.34 | 0 | |
| €26.00 | +0.17 | +0.7% | €26.00 | €26.00 | €26.00 | 0 | |
| €25.83 | -0.051 | -0.2% | €25.83 | €25.83 | €25.83 | 0 | |
| €25.88 | -0.10 | -0.4% | €25.88 | €25.88 | €25.88 | 0 | |
| €25.98 | -0.702 | -2.6% | €25.98 | €25.98 | €25.98 | 0 | |
| €26.69 | +0.852 | +3.3% | €26.69 | €26.69 | €26.69 | 0 |
- Ticker
- Frankfurt:EII
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
LEQEMBI Pen (Subcutaneous Formulation of LEQEMBI) Now Available in Japan for Patients with Early Alzheimer’s Disease
Latest earnings call · Aug 3, 2026
Eisai (Tokyo:4523) Q1 2027 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
Q2 2027 Earnings Presentation
Earnings · 33 slides
Latest news
Revenue of LEQEMBI (Preliminary Basis)
Oct 28, 2026
Closed €29.06 (+1.4%) on Oct 28, 2026
Notification Regarding Receipt of Dividend from a Consolidated Subsidiary
Oct 2, 2026
Closed €26.42 (-1.5%) on Oct 2, 2026
U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)
Sep 25, 2026
Closed €27.18 (+2.1%) on Sep 25, 2026
Leqembi® Pen subcutaneous formulation approved in Japan
Sep 16, 2026
Closed €27.36 (+4.9%) on Sep 16, 2026
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
Sep 16, 2026
Closed €27.36 (+4.9%) on Sep 16, 2026
Eisai and Osaka Prefecture Enter into Collaboration to Promote Awareness of Dementia and Mild Cognitive Impairment (MCI)
Sep 15, 2026
Closed €26.09 (+0.8%) on Sep 15, 2026
LEQEMBI (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
Sep 3, 2026
Closed €26.84 (+5.4%) on Sep 3, 2026
Eisai Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 59 in the last 12 months · 89 in all · newest Nov 12, 2026 · oldest 2025
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 3, 2026
- Decks
- 9 decks · latest Nov 10, 2026
Where Eisai Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4523 エーザイ · Home listing | Tokyo | Japan | JPY |
| OTC:ESAIY | OTC | United States | USD |
| gettex:EII | gettex | Germany | EUR |
| OTC:ESALF | OTC | United States | USD |
| Tradegate:EII | Tradegate | Germany | EUR |
| LS Exchange:855526 | LS Exchange | Germany | EUR |
| Frankfurt:EII · This page | Frankfurt | Germany | EUR |
| Lang & Schwarz:855526 | Lang & Schwarz | Germany | EUR |
| Hamburg:EII | Hamburg | Germany | EUR |
| Hanover:EII | Hanover | Germany | EUR |
| Munich:EII | Munich | Germany | EUR |
| Dusseldorf:EII | Dusseldorf | Germany | EUR |
| BIVA:4523N | BIVA | Mexico | MXN |
| BMV:4523N | BMV | Mexico | MXN |
| Dusseldorf:EIIA | Dusseldorf | Germany | EUR |
| Frankfurt:EIIA | Frankfurt | Germany | EUR |
| Stuttgart:EII | Stuttgart | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Eisai Co | Ltd. Investor Relations Department |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] |
Events
| Call | When | Status |
|---|---|---|
| Eisai (Tokyo:4523) Q1 2027 Earnings Call | Mon, Aug 03, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2026 Earnings Call | Fri, May 15, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2026 Earnings Call | Fri, Nov 07, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2026 Earnings Call | Tue, Aug 05, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2025 Earnings Call | Thu, May 15, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2025 Earnings Call | Fri, Nov 08, 2024 · 1:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2025 Earnings Call | Fri, Aug 02, 2024 · 2:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2024 Earnings Call | Thu, May 16, 2024 · 2:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2027 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q1 2027 Earnings Presentation | Earnings | 30 slides | Aug 3, 2026 |
| FY2025 Earnings Presentation | Earnings | 37 slides | May 15, 2026 |
| Corporate Update (November 2025) | Corporate update | 22 slides | Nov 13, 2025 |
| Q2 2026 Earnings Presentation | Earnings | 37 slides | Nov 7, 2025 |
| Fact Sheet (May 2014) | Fact sheet | 1 slide | May 2014 |
| Fact Sheet (March 2013) | Fact sheet | 1 slide | March 2013 |
| Fact Sheet (June 2011) | Fact sheet | 2 slides | June 2011 |
Filings
Cap table
Built by 6ix from Eisai Co., Ltd.’s releases
- Common shares
- 291,649,149
- Fully diluted
- 291,649,149
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 291,649,149 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 291,649,149 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eisai Co Other companies: Nuvation Bio Inc. (Ltd. Investor Relations Department · Since at least Mar 26, 2026); Biogen Inc. (Investor Relations Department · Since at least Jan 25, 2026) | Ltd. Investor Relations Department · Since at least Mar 26, 2026 |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] · Since at least Sep 16, 2026 |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] · Since at least Sep 16, 2026 |
Log in to ask 6ix AI your own questions about Eisai Co., Ltd.